| Ident. | Authors (with country if any) | Title |
|---|
| 000031 (2020) |
Etienne Dufranc [France] ; Arnaud Del Bello [France] ; Julie Belliere [France] ; Nassim Kamar [France] ; Stanislas Faguer [France] | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| 000048 (2020) |
Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni] | 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. |
| 000054 (2019) |
Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France] | [Treatment of giant cell arteritis]. |
| 000064 (2019) |
Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne] | Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis |
| 000067 (2019) |
Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse] | Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database. |
| 000068 (2019) |
Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France] | Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. |
| 000069 (2019) |
Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France] | Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis. |
| 000091 (2019) |
Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France] | Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. |
| 000094 (2019) |
Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France] | Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study. |
| 000097 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs |
| 000101 (2019) |
Sara Touhami [France] ; Eléonore Diwo [France] ; Pascal Sève [France] ; Salim Trad [France] ; Philip Bielefeld [France] ; Damien Sène [France] ; Sebastien Abad [France] ; Antoine Brézin [France] ; Pierre Quartier [France] ; Isabelle Koné Paut [France] ; Michel Weber [France] ; Christophe Chiquet [France] ; Marie-Hélène Errera [France] ; Jérémie Sellam [France] ; Patrice Cacoub [France] ; Gilles Kaplanski [France] ; Laurent Kodjikian [France] ; Bahram Bodaghi [France] ; David Saadoun [France] | Expert opinion on the use of biological therapy in non-infectious uveitis. |
| 000103 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses |
| 000107 (2019) |
Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raimon Sanmarti [Espagne] ; Min Bao [États-Unis] ; Jenny Devenport [États-Unis] ; Attila Pethö-Schramm [Suisse] | Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis |
| 000110 (2019) |
Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis] | Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs |
| 000112 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 000113 (2019) |
Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France] | Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis |
| 000118 (2019) |
Benjamin Castagné [France] ; Marie Viprey [France] ; Julie Martin [France] ; Anne-Marie Schott [France] ; Michel Cucherat [France] ; Martin Soubrier [France] | Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis |
| 000124 (2019) |
François Vercruysse [France] ; Thomas Barnetche [France] ; Estibaliz Lazaro [France] ; Emilie Shipley [France] ; François Lifermann [France] ; Alexandre Balageas [France] ; Xavier Delbrel [France] ; Bruno Fautrel [France] ; Christophe Richez [France] ; Thierry Schaeverbeke [France] ; Marie-Elise Truchetet [France] | Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy |
| 000126 (2019) |
Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France] | A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients. |
| 000140 (2018) |
J. Broner [France] ; E. Arnaud [France] | [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients]. |
| 000141 (2018) |
M. Samson [France] ; B. Bonnotte [France] | [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?] |
| 000143 (2018) |
X. Grimaux [France] ; S. Leducq [France] ; P. Goupille [France] ; A. Aubourg [France] ; E. Miquelestorena-Standley [France] ; M. Samimi [France] | [Aphthous mouth ulcers as an initial manifestation of sécukinumab-induced inflammatory bowel disease]. |
| 000145 (2018) |
Anaïs Huwart [France] ; Florent Garrigues [France] ; Sandrine Jousse-Joulin [France] ; Thierry Marhadour [France] ; Dewi Guellec [France] ; Divi Cornec [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France] | Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab |
| 000147 (2018) |
Alvise Berti [États-Unis] ; Divi Cornec [France] ; Jose R. Medina Inojosa [États-Unis] ; Eric L. Matteson [États-Unis] ; M Hassan Murad [États-Unis] | Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index. |
| 000149 (2018) |
Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France] | Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review. |
| 000150 (2018) |
Maxime Samson [France] ; Hervé Devilliers [France] ; Kim Heang Ly [France] ; François Maurier [France] ; Boris Bienvenu [France] ; Benjamin Terrier [France] ; Pierre Charles [France] ; Loïc Guillevin [France] ; Jean-François Besancenot [France] ; Eric Liozon [France] ; Anne Laure Fauchais [France] ; Romaric Loffroy [France] ; Christine Binquet [France] ; Sylvain Audia [France] ; Raphaèle Seror [France] ; Xavier Mariette [France] ; Bernard Bonnotte [France] | Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. |
| 000151 (2018) |
Paul Decker [France] ; Pierre Olivier [France] ; Jessie Risse [France] ; Stéphane Zuily [France] ; Denis Wahl [France] | Tocilizumab and refractory Takayasu disease: Four case reports and systematic review. |
| 000158 (2018) |
E. Ebstein [France] ; H-K Ea [France] | Spontaneous resolution of Epstein-Barr virus-induced haemophagocytic lymphohistiocytosis in Still's disease treated by tocilizumab: a case report. |
| 000159 (2018) |
Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France] | Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| 000160 (2018) |
Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France] | Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. |
| 000162 (2018) |
Adamah Amouzougan [France] ; Delphine Dénarié [France] ; Hubert Marotte [France] ; Xavier Roblin [France] ; Thierry Thomas [France] | Rheumatoid arthritis treated with tocilizumab in two patients with complicated chronic liver disease with portal hypertension. |
| 000163 (2018) |
Pauline Richebé [France] ; Florian Bailly [France] ; Louise Laure Mariani [France] ; Paola Sanchez Pena [France] ; Jean Michel Pedespan [France] ; Bruno Fautrel [France] | Report of two cases of tocilizumab induced recurrent meningitis or meningoencephalitis. |
| 000175 (2018) |
Marc Scherlinger [France] ; Sophie Alain [France] ; Christophe Richez [France] | Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis. |
| 000178 (2018) |
P. Tétu [France] ; A. Hamelin [France] ; P. Moguelet [France] ; A. Barbaud [France] ; A. Soria [France] | Management of hypersensitivity reactions to Tocilizumab. |
| 000184 (2018) |
Frits Van Rhee [États-Unis] ; Peter Voorhees [États-Unis] ; Angela Dispenzieri [États-Unis] ; Alexander Foss [Norvège] ; Gordan Srkalovic [États-Unis] ; Makoto Ide [Japon] ; Nikhil Munshi [États-Unis] ; Stephen Schey [Royaume-Uni] ; Matthew Streetly [Royaume-Uni] ; Sheila K. Pierson [États-Unis] ; Helen L. Partridge [États-Unis] ; Sudipto Mukherjee [États-Unis] ; Dustin Shilling [États-Unis] ; Katie Stone [États-Unis] ; Amy Greenway [États-Unis] ; Jason Ruth [États-Unis] ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan [États-Unis] ; Raj Jayanthan [États-Unis] ; Elaine S. Jaffe [États-Unis] ; Heather Leitch [Canada] ; Naveen Pemmaraju [États-Unis] ; Amy Chadburn [États-Unis] ; Megan S. Lim ; Kojo S. Elenitoba-Johnson ; Vera Krymskaya [États-Unis] ; Aaron Goodman [États-Unis] ; Christian Hoffmann [Allemagne] ; Pier Luigi Zinzani [Italie] ; Simone Ferrero [Italie] ; Louis Terriou [France] ; Yasuharu Sato [Japon] ; David Simpson [Nouvelle-Zélande] ; Raymond Wong [Hong Kong] ; Jean-Francois Rossi [France] ; Sunita Nasta [États-Unis] ; Kazuyuki Yoshizaki [Japon] ; Razelle Kurzrock [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Corey Casper [États-Unis] ; Eric Oksenhendler [France] ; David C. Fajgenbaum [États-Unis] | International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease |
| 000187 (2018) |
William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France] | Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE. |
| 000193 (2018) |
Y. Mansour [France] ; A. Lambert [France] ; M. Tebacher-Alt [France] ; J L Pasquali [France] ; D. Lipsker [France] | Eruptive nevi under tocilizumab: first case report and data analysis. |
| 000194 (2018) |
Arsene Mekinian [France] ; Mathieu Resche-Rigon [France] ; Cloé Comarmond [France] ; Alessandra Soriano ; Joel Constans [France] ; Laurent Alric [France] ; Patrick Jego [France] ; Florian Busato [France] ; Matthieu Cabon [France] ; Robin Dhote [France] ; Lazaro Estibaliz [France] ; Isabelle Koné-Paut [France] ; Cédric Landron [France] ; Christian Lavigne [France] ; Bertrand Lioger [France] ; Martin Michaud [France] ; Marc Ruivard [France] ; Karim Sacre [France] ; Jacques Eric Gottenberg [France] ; Francis Gaches [France] ; Tiphaine Goulenok [France] ; Carlo Salvarani ; Patrice Cacoub [France] ; Olivier Fain [France] ; David Saadoun [France] | Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients. |
| 000198 (2018) |
K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne] | ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). |
| 000206 (2018) |
Jennifer Pasquier [Qatar, États-Unis, France] ; Marie Gosset [France] ; Caroline Geyl [France] ; Jessica Hoarau-Véchot [Qatar] ; Audrey Chevrot [France] ; Marc Pocard [France] ; Massoud Mirshahi [France] ; Raphael Lis [États-Unis] ; Arash Rafii [Qatar, États-Unis] ; Cyril Touboul [France] | CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer |
| 000208 (2018) |
Maxime Samson [Espagne] ; Georgina Espígol-Frigolé [Espagne] ; Nekane Terrades-García [Espagne] ; Sergio Prieto-González [Espagne] ; Marc Corbera-Bellalta [Espagne] ; Roser Alba-Rovira [Espagne] ; José Hernández-Rodríguez [Espagne] ; Sylvain Audia [France] ; Bernard Bonnotte [France] ; Maria C. Cid [Espagne] | Biological treatments in giant cell arteritis & Takayasu arteritis. |
| 000210 (2018) |
Pauline Baudart [France] ; Johann Cesini [France] ; Christian Marcelli [France] | Atypical juxta-articular form of Dercum's disease in a patient treated with tocilizumab for rheumatoid arthritis. |
| 000211 (2018) |
Valérie Devauchelle-Pensec [France] ; Lea Saraux [France] ; Jean Marie Berthelot [France] ; Michel De Bandt [France] ; Divi Cornec [France] ; Dewi Guellec [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] | Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable. |
| 000212 (2018) |
Sarah Fleischer [Allemagne] ; Stefanie Ries [Allemagne] ; Ping Shen [Allemagne] ; Alix Lheritier [France] ; Frédéric Cazals [France] ; Gerd R. Burmester [Allemagne] ; Thomas Dörner [Allemagne] ; Simon Fillatreau [Allemagne] | Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis. |
| 000215 (2018) |
Alice Horisberger [Suisse] ; Stefano La Rosa [Suisse] ; Jean-Philippe Zurcher [Suisse] ; Stefan Zimmermann [Suisse] ; Francois Spertini [Suisse] ; George Coukos [Suisse] ; Michel Obeid [Suisse, France] | A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy |
| 000224 (2017) |
M. Gaume [France] ; L. Marie-Hardy [France] ; F. Larousserie [France] ; M. Lavielle [France] ; C. Roux [France] ; P. Leclerc [France] ; A. Paugam [France] ; D. Archambeau [France] ; L. Eyrolle [France] ; R. Gauzit [France] ; O. Lortholary [France] ; P. Anract [France] ; L. Epelboin [France] ; D. Salmon [France] | [Histoplasma capsulatum bone and joint infection]. |
| 000225 (2017) |
M. Samson [France] ; B. Bonnotte [France] | [From pathogenesis of giant cell arteritis to new therapeutic targets]. |
| 000226 (2017) |
Cosimo Bruni [Italie] ; Emanuela Praino [Italie] ; Yannick Allanore [France] ; Oliver Distler [Suisse] ; Armando Gabrielli [Italie] ; Florenzo Iannone [Italie] ; Marco Matucci-Cerinic [Italie] | Use of biologics and other novel therapies for the treatment of systemic sclerosis. |
| 000228 (2017) |
Fabrice Cognasse [France] ; Olivier Garraud [France] ; Hubert Marotte [France] | Unlike tocilizumab, etanercept slightly increases experimental thrombin-induced aggregation in healthy individuals. |
| 000232 (2017) |
Nihal Martis [France] ; David Chirio [France] ; Viviane Queyrel-Moranne [France] ; Marie-Christine Zenut [France] ; Fanny Rocher [France] ; Jean-Gabriel Fuzibet [France] | Tocilizumab-induced hypofibrinogenemia: A report of 7 cases. |
| 000233 (2017) |
Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France] | Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. |
